Document is current

Any future updates will be listed below

Exenatide infusion decreases atrial natriuretic peptide levels by reducing cardiac filling pressures in type 2 diabetes patients with decompensated congestive heart failure

Crossref DOI link: https://doi.org/10.1186/S13098-015-0116-2

Published: 2016-12

Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY

About CrossMark